Information  X 
Enter a valid email address

European Lithium Ltd (EUR)

  Print      Mail a friend

Friday 16 August, 2019

European Lithium Ltd

Issue of Shares

RNS Number : 3150J
European Lithium Limited
16 August 2019
 

European Lithium Ltd

("European Lithium", "EUR" or "the Company")

Issue of Shares

European Lithium Limited (ASX:EUR, FRA:PF8, VSE:ELI, NEX:EUR) (the Company) advises that 1,016,411 fully paid shares (the Shares) have been issued to MEF I LP as announced on 7 September 2018. The full announcement can be seen at: https://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=EUR&timeframe=D&period=M6

 

Application has been made for the Shares to be admitted to trading on NEX ("Admission"). Admission is expected to occur at 8:00am on or around 22nd August 2019. Following Admission, the Company's issued share capital will comprise 592,158,210 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.  The above figure of 592,158,210 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

The full ASX announcement can be seen at: https://www.asx.com.au/asx/share-price-research/company/EUR

 

- END -

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage

[email protected]

 

 

NEX Corporate Adviser

+44 207 220 1666

James Joyce


James Sinclair-Ford




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXGRGDIRXBBGCL

a d v e r t i s e m e n t